Eris Lifesciences supports innovation in Continuing Medical Education (CME) – launches the first-ever ‘Metabolic Roadinar’

Eris Lifesciences supports innovation in Continuing Medical Education (CME) – launches the first-ever ‘Metabolic Roadinar’

Continuing Medical Education (CME) is an integral part of medical communication targeted to help clinicians improve medical outcomes in patients. Due to restrictions that followed as a result of the Covid19 outbreak, seminars witnessed a shift in their formats, with healthcare professionals adopting webinars as the new platform in the post-pandemic era. Now webinars are all set to see a renewed approach towards delivering medical education, and a new term coined to present the format is “Roadinar”. In order to find an innovative solution to maintain high engagement levels in CMEs, Eris Lifesciences supports this innovative, first-of-its-kind initiative presented by the Metabolic Health Digest, the first edition of the Metabolic Roadinar – an educational travelogue featuring 18 well-known doctors from across the country spread across 9 episodes.

Having covered 45,000+ medical practitioners since the start of the pandemic through digital interactions, Eris has been at the forefront in delivering knowledge sessions for doctors in the fields of diabetes, heart failure, Covid impact on cardio-metabolic health and general immunity. Eris has carved out a niche for itself in the cardio-metabolic space through its unique Patient Care Initiatives platform and ongoing investment in India-centric studies to generate cutting-edge scientific evidence based on the local population. An example of this is the India Heart Study (IHS), which is the only study of its kind on hypertension based on the Indian population. In addition to having become a benchmark in its field, the study was accepted and published in the Journal of Hypertension, the official journal of the International Society of Hypertension and the European Society of Hypertension.

The Metabolic Roadinar is in line with Eris’ commitment to support innovative thinking and deliver future-forward, critical information to the medical fraternity.

News Links

Copyright © 2022 Eris Lifesciences Limited. All Rights Reserved.